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Abstract
Objective: The precise pathogenesis or neural correlates underlying levodopa-
induced dyskinesia (LID) remains poorly understood. There is growing evi-
dence of the involvement of the cerebellum in Parkinson’s disease (PD). The
present study evaluated the role of motor cerebellar connectivity in determining
vulnerability to LID. Methods: We enrolled 25 de novo patients with PD who
developed LID within 5 years of levodopa treatment, 26 propensity score-
matched PD patients who had not developed LID, and 24 age- and sex-
matched healthy controls. We performed a comparative analysis of resting-state
functional connectivity (FC) between the motor cerebellum and whole brain
between the groups. Results: The patients with PD had increased FC bewteen
the motor cerebellum and posterior cortical and cerebellar regions, while no
gray matter regions had decreased FC with the motor cerebellum compared to
the control participant. The patients with PD who were vulnerable to the devel-
opment of LID had a significantly higher FC between the motor cerebellum
lobule VIIIb and the left inferior frontal gyrus than those who were resistant to
LID development. The connectivity of the motor cerebellum and left inferior
frontal gyrus was negatively correlated with the latency from PD onset to the
occurrence of LID. Interpretation: Increased FC between the motor cerebellum
and left inferior frontal gyrus in de novo patients with PD could be an impor-
tant determinant of vulnerability to LID.
Introduction
Although levodopa is the most effective treatment for
Parkinson’s disease (PD), its chronic administration can
be complicated by disabling involuntary movement,
levodopa-induced dyskinesia (LID). The likelihood of
developing LID is 40% within 4–6 years of levodopa ther-
apy,1 and its cumulative incidence increases up to 90 %
in patients with PD taking levodopa for more than
10 years.2 LID is one of the most debilitating effects of
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levodopa therapy, and is associated with a poor quality of
life and health-related costs.3
The exact pathogenesis or neural correlates underlying
LID remain poorly understood. Presynaptic dopaminergic
deafferentation to the striatum due to nigrostriatal degen-
eration is a prerequisite for the development of LID.4 The
pulsatile stimulation of dopamine receptors and alteration
of nondopaminergic neurotransmitters simultaneously
contribute to the development of LID via abnormal plas-
ticity in the striatum, cortex, and their connections.5,6
Structural and functional magnetic resonance images have
found increased prefrontal volume and its altered connec-
tivity with the putamen to be associated with the condi-
tion.7,8 Aberrant dopaminergic modulation of the
connectivity between the putamen and motor areas has
been supposed as a possible substrate and predictor for
the development of LID.9
Apart from the traditional concept of the cortico-basal
ganglia-thalamo-cortical loop as a motor circuit in PD,
the role of the cerebellum has recently been emphasized;
several studies have identified reciprocal links between the
basal ganglia and cerebellum in animals10 and in vivo evi-
dence of alteration in the cerebello-thalamo-cortical path-
way in PD.11 In terms of the cerebellar involvement in
LID, deep brain stimulation of the subthalamic nucleus
or globus pallidus has been reported to normalize meta-
bolism in the cerebellum,12,13 and transcranial magnetic
stimulation (TMS) over the cerebellum has shown
promising results in alleviating LID.14 Despite many stud-
ies investigating the mechanisms of LID, there have been
no previous studies to evaluate the relationship between
cerebellar connectivity and LID in patients with PD.
In the present study, we hypothesized that drug-na€ıve
PD patients who were vulnerable to the future develop-
ment of LID would demonstrate a different pattern of
functional connectivity (FC) of the motor cerebellar seed
compared to those who were resistant to LID. Thus, to
elucidate the role of the motor cerebellum in the patho-
physiology of LID, we explored the FC between the motor
cerebellum and whole brain areas in de novo patients
with PD who were followed for more than 5 years during
levodopa treatment.
Methods
Participants
We retrospectively reviewed the database from the Move-
ment Disorders outpatient clinic at the Yonsei University
Health System from September 2008 to August 2013. We
enrolled 27 patients with PD who developed LID within
5 years of levodopa treatment. Among patients with PD
who had not developed LID within 5 years of levodopa
treatment, we recruited 27 patients using a propensity score
matching method to match each patient 1:1 in terms of
age, sex, disease duration, and parkinsonian motor score.
All patients with PD underwent baseline brain magnetic
resonance imaging (MRI) at the de novo state and were
followed for more than 5 years. The diagnosis of PD was
based on the clinical diagnostic criteria of the United King-
dom PD Society Brain Bank, and only patients diagnosed
with PD who responded to dopaminergic medication dur-
ing the follow-up period (≥6 months) were included in the
present study. All patients with PD had undergone N-(3-
[18F]fluoropropyl)-2b-carbon ethoxy-3b-(4-iodophenyl)
nortropane (18F-FP-CIT) positron emission tomography
(PET) imaging at the time of their PD diagnosis, which
revealed decreased uptake in the posterior putamen.
Patients with PD visited outpatient clinic every 3 to
6 months, and two movement disorders experts (Y.H.S.,
P.H.L.) carefully examined for the presence of LID based
on history from patients and caregivers or direct neurologi-
cal examination at every visit. We regarded the date on
which the PD patients or their caregivers reported the
occurrence of LID or the date it was first observed in the
clinic as the date of LID occurrence. Since the cumulative
incidence of LID increases with the duration of levodopa
intake and the mean latency from the initiation of levo-
dopa treatment to LID in patients with PD was approxi-
mately 5 years,15 we divided the PD patients into two
groups: a LID-resistant group (PD-LID-) who did not
develop LID within 5 years of levodopa treatment and a
LID-vulnerable group (PD-LID+) who developed LID
within 5 years of levodopa administration. Due to image
quality/process assurance, one patient in the PD-LID-
group and two patients in the PD-LID + group were fur-
ther excluded; therefore a total of 51 patients with PD (PD-
LID- group, n = 26; PD-LID + group, n = 25) were
included in the study. Twenty-four healthy control individ-
uals matched for age and sex with no focal neurologic dis-
eases and normal cognitive function (scores ≥ 26 on
Korean version of the Mini-Mental State Examination [K-
MMSE]) were also recruited. The exclusion criteria
included an evidence of atypical parkinsonism; focal brain
lesions, severe white matter hyperintensities,16 multiple
lacunes in the basal ganglia, or hydrocephalus on MRI;
other neurological, psychiatric, or metabolic illnesses; or
patients with PD who displayed parkinsonian symptoms
before age 40 because young-onset PD patients are extre-
mely high risk for LID.17
Parkinsonian motor symptoms were assessed during
the drug-na€ıve state at the time of 18F-FP-CIT PET acqui-
sition using the Unified PD Rating Scale (UPDRS) motor
(part III) subscale. The levodopa dose was calculated
according to the method described in a previous study.18
Patients who were taking amantadine at LID onset were
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excluded because it exerts an antidyskinetic effect. The K-
MMSE was used to assess general cognition.
The present study was approved by the Institutional
Review Board of Yonsei University College of Medicine
and informed consent was obtained from all participants.
Neuroimaging acquisition
All subjects underwent MRI scanning with a 3.0 Tesla
MRI scanner (Achieva, Philips Medical System, Best,
Netherlands). A detailed description is provided in Data
S1.
Preprocessing of functional MRI data
The resting-state functional MRI data were processed
using Analysis of Functional NeuroImages (AFNI) soft-
ware (http://afni.nimh.nih.gov/afni).19 A detailed descrip-
tion is provided in Data S2.
FC analyses
The motor cerebellum was defined by anterior lobe (lob-
ule I–V) and lobule VI, VIIb, VIIIa, and VIIIb according
to previous studies,20–22 within both cerebellar hemi-
spheres and vermis, using masks created with Probabilis-
tic atlas of the human cerebellum.23 A detailed
description is provided in Data S3.
Group comparisons of FC
In comparisons of FC of motor cerebellum, we used age,
sex, years of education, and total K-MMSE score as
covariates to adjust potential confounders that can affect
FC and to exclude the influence of cognitive function on
FC in all group comparisons. First, we compared the FC
of motor cerebellum between controls and patients with
PD to investigate PD-specific changes in FC from motor
cerebellum. For five motor cerebellar seeds, we performed
a two-sample t-test on the group gray mask with above
covariates. We further performed a correction for five
comparisons for five seeds. The corrected significance
level was set at Pa-value < 0.05/5 (uncorrected per-voxel
height threshold of two-tailed P-value < 0.005 with a
minimum cluster size of 267 voxels). Second, we com-
pared the FC of motor cerebellum among the control,
PD-LID-, and PD-LID + groups to investigate LID-re-
lated change in FC from motor cerebellum. For five
motor cerebellar seeds, we performed analysis of variance
on the group gray mask with the same covariates with
threshold at uncorrected P < 0.05 (Fig. S1). Then, we
performed subgroup comparison between the two groups
for five FC maps. We further performed a correction for
three post-hoc subgroup comparisons and five compar-
isons for five motor cerebellar seeds. The corrected signif-
icance level was set at Pa-value < 0.05/15 (uncorrected
per-voxel height threshold of two-tailed P-value < 0.005
with a minimum cluster size of 120 voxels).
Statistical analyses
For baseline demographics and clinical characteristics of
all participants, we used a two-sample t-test or an analysis
of variance for continuous variables and Pearson’s v2 test
for categorical variables. A partial correlation analysis
using age, sex, disease duration, and parkinsonian motor
score as covariates was conducted to evaluate the relation-
ship between the latency from levodopa start to the devel-
opment of LID and the FC from the motor cerebellar
seed. The data were analyzed using SPSS software version
23 (IBM Corporation, Armonk, NY, USA). P-values less
than 0.05 were considered significant.
Results
Demographic and clinical characteristics
The baseline demographics and clinical characteristics of
the participants are summarized in Table 1. Age, sex,
years of education, and total K-MMSE score were compa-
rable among the controls and PD patients. Between the
PD-LID- and PD-LID + groups, there were no differences
in the disease duration, follow-up duration, levodopa
duration, levodopa dose at the last follow-up, or UPDRS
motor score. In the PD-LID + group, the latency from
levodopa start to LID development was 0.5–4.9 years and
its mean and standard deviation was 2.5  1.3 years.
Comparison of FC from the motor
cerebellum between the control and PD
groups
The patients with PD had increased FC between cerebellar
lobule VI and the right middle temporal gyrus (Fig. 1A). In
the seed of VIIIb, the patients with PD exhibited increased
FC with the left cerebellum, posterior cingulate cortex, and
left inferior parietal region (Fig. 1B). No regions had altered
FC from cerebellar lobules I–V, VIIb, and VIIIa in the PD
group compared with the control group.
Comparison of FC from the motor
cerebellum between the control, PD-LID-,
and the PD-LID + groups
Compared to the controls, the PD-LID- group had
increased FC between lobule VI and right superior
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parietal lobule and between lobule VIIIb and posterior
cingulate cortex, left inferior parietal lobule, left calcarine
gyrus, left cerebellum, and right angular gyrus compared
to the control group (Fig. S2), while the PD-LID + group
had increased FC between lobule VI and left paracentral
lobule and right superior occipital gyrus, between lobule
VIIb and right calcarine gyrus, between lobule VIIIa and
right fusiform gyrus, and between lobule VIIIb and right
superior parietal lobule, left middle temporal gyrus, and
left calcarine gyrus (Fig. S3). In a direct comparison of
FC from the motor cerebellar seed between the PD-LID-
and PD-LID + groups, the PD-LID + group had signifi-
cantly increased FC between cerebellar lobule VIIIb and
the left prefrontal cortex, maximally with the left inferior
frontal gyrus (Fig. 2). The averaged z-value of FC between
cerebellar lobule VIIIb and the left inferior frontal gyrus
in the PD-LID + group was higher than the control or
PD-LID- group (Fig. 3).
Correlation between motor cerebellar
connectivity and latency to develop LID
In the PD-LID + group, the z-value of FC between cere-
bellar lobule VIIIb and the left inferior frontal gyrus was
negatively associated with the latency from levodopa start
to the development of LID (r = 0.559, P = 0.008) after
adjusting for age, sex, disease duration, and parkinsonian
motor score (Fig. 4). There were no correlations between
the z-value of FC and age, UPDRS motor score, or total
K-MMSE score.
Discussion
The present study analyzed the association between the
development of LID and FC of the motor cerebellum in
de novo patients with PD. The major findings were as fol-
lows. First, patients with PD had increased FC between
the motor cerebellum and posterior cortical regions com-
pared to the control subjects. Second, PD patients who
were vulnerable to the development of LID had a signifi-
cantly higher FC between the motor cerebellum and left
inferior frontal gyrus than those who were resistant to its
development. Third, the connectivity of the motor cere-
bellum and left inferior frontal gyrus was negatively corre-
lated with the latency from PD onset to the occurrence of
LID.
Increasing evidence suggests that the cerebellum and its
connectivity are altered in PD, which reported increased
connectivity or hyperactivity in cerebellum. Liu et al.
found that the cerebellum showed enhanced connectivity
with the bilateral dentate nucleus in de novo patients with
PD.24 Festini et al. reported dopamine-dependent cerebel-
lar connectivity, which showed increased cerebellar con-
nectivity in off-medication and decreased connectivity in
Table 1. Demographics and clinical characteristics of patients with normal control and Parkinson’s disease.
Variables Control PD-LID- PD-LID+ P-value
Number 24 26 25
Age, years 66.1  8.9 67.8  8.4 65.7  9.0 0.625
Sex, female, n (%) 13 (54.2) 13 (50.0) 12 (48.0) 0.908
Education, years 12.2  3.4 10.6  4.8 9.6  4.5 0.110
Total K-MMSE score 27.3  1.1 26.2  2.4 26.7  2.9 0.101
Disease duration, months 14.2  10.4 18.0  13.1 0.236
Follow-up duration, years 6.0  0.8 6.1  0.8 0.617
Duration of levodopa therapy, year 6.0  0.7 5.9  0.7 0.593
Levodopa dose at the last follow-up, mg 509.1  204.4 516.0  148.9 0.891
UPDRS motor score 20.4  9.5 24.1  11.4 0.395
Latency from levodopa start to LID development, years 2.5  1.3
Values are expressed as mean  standard deviation or number (percentage).
PD, Parkinson’s disease; LID, levodopa-induced dyskinesia; MRI, magnetic resonance imaging; CCSIT, Cross-Cultural Smell Identification Test; BDI,
Beck Depression Inventory; K-MMSE, the Korean version of the Mini-Mental State Examination; UPDRS, Unified Parkinson’s Disease Rating Scale
Figure 1. Comparison of the functional connectivity (FC) from the motor cerebellum between the control and Parkinson’s disease (PD) groups.
The control and PD groups showed different FC when cerebellar lobule VI or VIIIb was used as a seed region. (A) The PD group had increased FC
between cerebellar lobule VI and cluster 1 compared to the control group. (B) The PD group had increased FC between cerebellar lobule VIIIb and
cluster 1 - 3 compared to the control group. Results are based on analysis of covariance adjusting for age, sex, years of education, and total K-
MMSE score. The yellow colour indicates brain regions where the control group had a higher FC than the PD group, while the blue colour
indicates brain regions where the PD group had a higher FC than the control group. Black arrow in sagittal section indicates each cluster of
significance. The brain images are displayed in neurological convention.
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on-medication compared with the control subjects.25
Increased cerebellar activation in PD was evident during
motor execution or motor learning26,27 as well as resting
state.28 In the present study, we investigated the FC
between the motor cerebellum and cortical gray matter in
PD patients without exposure to dopaminergic medica-
tion. We found that the motor cerebellum, especially in
lobule VI and VIIIb, had increased FC with posterior cor-
tical areas in drug-na€ıve PD patients. Intriguingly, no
motor areas in cortical and subcortical regions showed
altered FC with motor cerebellum. Given that posterior
cerebral hypometabolism or altered FC is related to cog-
nitive dysfunction in PD,29,30 one possible explanation is
that increased networks in these areas may be attributable
to the cognitive role of the seeds, rather motor dysfunc-
tion in PD, although we controlled for years of education
and total K-MMSE score for covariates. Of the motor
cerebellar regions, anterior lobe (lobule I–V) and lobules
VIIIb are consistently involved in motor function, while
whether cerebellar lobule VI, VIIb, and VIIIa are respon-
sible for motor or cognitive functions varies from study
to study.20,31,32 Thus, it can be inferred that precise
anatomical segregation of motor and cognitive cerebellum
is difficult and the FC of cerebellum is more predominant
in cognitive aspect in early PD than motor aspect. Further
studies are necessary to address whether altered motor
cerebellum connectivity is a compensatory mechanism for
motor dysfunction or an overall reflection of a pathologic
change in PD.33
Interestingly, the present study demonstrated that the
motor cerebellar connectivity to the left inferior frontal
gyrus was enhanced at the time of the diagnosis in PD-
LID + patients compared to PD-LID- patients. The role
of the prefrontal cortex in the development of LID is not
yet elucidated. Cerasa et al. reveal that the prefrontal cor-
tex is critical in the pathophysiology of LID.7,8 PD
patients with LID had increased gray matter volume in
the bilateral inferior frontal gyrus, which was more
prominent on the right side, and underactivation of the
right inferior frontal gyrus compared with those without
LID. Contrarily, Herz et al. found that dopaminergic
modulation of resting-state connectivity between the
putamen and primary sensorimotor cortex or supplemen-
tary motor area, not the inferior frontal gyrus, predicted
the presence or severity of LID.9 In the present study, the
connectivity between the cerebellum and left inferior
frontal gyrus was comparable between the patients with
PD and control participants, but it was significantly
higher in the PD-LID + group than the control and PD-
LID- groups. Moreover, the connectivity of the motor
cerebellum and left inferior frontal gyrus was negatively
correlated with the latency from PD onset to the
Figure 2. Direct comparison of the functional connectivity (FC) from the motor cerebellum between the PD-LID- and the PD-LID+ groups. The
PD-LID- and PD-LID+ groups showed different FC when cerebellar lobule VIIIb was used as a seed region. (A) The PD-LID+ group had increased
FC between cerebellar lobule VIIIb and cluster 1 compared to the PD-LID- group. Results are based on analysis of covariance adjusting for age,
sex, years of education, and total K-MMSE score. The yellow colour indicates brain regions where the PD-LID- group had a higher FC than the
PD-LID+ group, while the blue colour indicates brain regions where the PD-LID+ group had a higher FC than the PD-LID- group. Black arrow in
sagittal section indicates the cluster of significance. The brain images are displayed in neurological convention.
2256 ª 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Cerebellum and Levodopa-Induced Dyskinesia H. S. Yoo et al.
occurrence of LID. The inferior frontal gyrus, either left
or right, is critical for inhibitory control over motor
responses.34,35 One study using TMS found a decreased
inhibitory control of the inferior frontal cortex over pri-
mary motor area.36 Therefore, it can be postulated that
alterations or plasticity in the inferior frontal gyrus might
disinhibit abnormal cortico-basal ganglia circuit or aggra-
vate motor cortex plasticity. Based on the evidence that
the prefrontal cortex is activated in PD patients with LID,
Rektorova et al. administered TMS over the left dorsolat-
eral prefrontal cortex and found improvement of LID and
decrement in the amplitude of motor-evoked potential,
Figure 3. Bar graph (mean  1 standard deviation) showing the comparison of the z-values of functional connectivity (FC) between cerebellar
lobule VIIIb and the left inferior frontal gyrus (IFG) among the control and PD groups.
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suggesting a prefrontal contribution to motor cortex inhi-
bition.37 Several studies have demonstrated the existence
of the intrinsic connectivity between the lateral prefrontal
region and cerebellum, which suggests the role of the
cerebellum in cognitive function.38 Therefore, we pro-
vided new evidence that abnormally increased lateral pre-
frontal-cerebellar connectivity can have a role in
ineffective motor control, inferring that the inferior fron-
tal gyrus and its connectivity play an important role in
the pathogenesis of LID.
The role of the cerebellum in LID has been strongly
supported by the research of TMS over the cerebellum,
which showed promising results in alleviating LID.14 Inhi-
bitory cerebellar stimulation is thought to facilitate cere-
bello-thalamo-cortical afferent input to the primary
motor cortex and improve responsiveness of the primary
motor cortex and sensorimotor plasticity, thereby reduc-
ing LID.39 In conjunction with our findings, inhibitory
cerebellar stimulation may reduce the enhanced pre-
frontal-cerebellar connectivity and modulate motor com-
plications in PD. Since baseline connectivity is important
in determining when LID will occur, we also anticipate
delaying the occurrence of LID if we select PD patients
with increased connectivity and apply TMS over the cere-
bellum in the de novo state.
The present study had several limitations. First, this
study was based on a relatively small sample, which
limits the generalizability of our results. However, we
applied strict exclusion criteria to enroll drug-na€ıve PD
patients who were susceptible to LID and performed a
propensity score match to enroll those who were resis-
tant to LID. Therefore, the results of the altered cere-
bellar FC may purely reflect the influence of LID.
Second, the patients with PD were arbitrarily divided
into the LID-vulnerable and LID-resistant groups based
on the occurrence of LID within 5 years of levodopa
treatment. The cutoff years were based on one study
that the mean time from levodopa initiation to the
onset of LID was approximately 5 years.15 Third, the
onset of LID was determined by retrospective reports
by the patients or observations made during regular
follow-up evaluations in the outpatient clinic for move-
ment disorders. Thus, the onset of these complications
may have occurred earlier than reported. Fourth, we
did not conduct functional MRI at the onset of LID,
which would better reflect the changes in FC in LID
patients. However, we cannot exclude the influence of
chronic levodopa administration or disease progression
on altered FC. Measuring FC in the absence of
dopaminergic medication and in the early stages would
be an effective method to study the exclusive functional
changes associated with the future development of LID.
Fifth, it would be preferable to measure the severity of
LID as well as the onset timing of LID together to
Figure 4. Scatter plot with a regression line showing the relationship between the z-values of functional connectivity (FC) between cerebellar
lobule VIIIb and the left inferior frontal gyrus (IFG) and the latency from levodopa start to the development of levodopa-induced dyskinesia (LID).
Gray shading indicates 95% confidence interval of the regression line.
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investigate the association between cerebellum connec-
tivity and LID.
To conclude, we demonstrated that abnormally increased
connectivity between the motor cerebellum and left inferior
frontal gyrus in de novo PD patients could affect the likeli-
hood of developing early LID during long-term levodopa
treatment. These results provide a new perspective in the
investigation of the role of the motor cerebellum in PD and
its contribution to the pathophysiology of LID.
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Data S1. Neuroimaging acquisition
Data S2. Preprocessing of functional MRI data
Data S3. Functional connectivity analyses
Table S1. Regions showing significant differences in func-
tional connectivity between the groups
Figure S1. F-maps of the functional connectivities from
the motor cerebellum among the control, PD-LID-, and
PD-LID + groups. Results are based on analysis of covari-
ance adjusting for age, sex, years of education, and total
K-MMSE score. The red to yellow color indicates brain
regions where the control, PD-LID-, and PD-
LID + groups had significantly different functional con-
nectivities from each motor cerebellar seed. The brain
images are displayed in neurological convention.
Figure S2. Comparison of the functional connectivities
from the motor cerebellum between the control and PD-
LID- groups. The control and PD-LID- groups showed
different functional connectivities when cerebellar lobule
VI or VIIIb was used as a seed region. Results are based
on analysis of covariance adjusting for age, sex, years of
education, and total K-MMSE score. The yellow color
indicates brain regions where the control group had a
higher functional connectivity than the PD-LID- group,
while the blue color indicates brain regions where the
PD-LID- group had a higher functional connectivity than
the control group. Black arrow in sagittal section indicates
each cluster of significance. The brain images are dis-
played in neurological convention.
Figure S3. Comparison of the functional connectivities
from the motor cerebellum between the control and PD-
LID + groups. The control and PD groups showed differ-
ent functional connectivities when cerebellar lobule VI,
VIIb, VIIIa, or VIIIb was used as a seed region. Results
are based on analysis of covariance adjusting for age, sex,
years of education, and total K-MMSE score. The yellow
color indicates brain regions where the control group had
a higher functional connectivity than the PD-
LID + group, while the blue color indicates brain regions
where the PD-LID + group had a higher functional con-
nectivity than the control group. Black arrow in sagittal
section indicates each cluster of significance. The brain
images are displayed in neurological convention.
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